LP Coil System RBYPCLP15-BRecalls & reported problems
Penumbra, Inc. · Packing Coil LP, 15cm · Class 2 · Implant
All models of LP Coil System (38)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00815948026179), received between Nov 23, 2024 and Dec 11, 2025 — classified as 4 malfunctions.
The most frequently reported specific device problem is “Premature Separation” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Premature Separation3
- Material Deformation1
- Migration1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
- Foreign Body In Patient1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 11, 2025Premature Separation; Premature Separation
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE FOR AN ARTERIOVENOUS MALFORMATION (AVM) USING PACKING COIL LPS AND A NON-PENUMBRA MICROCATHETER. DURING THE PROCEDURE, THE PHYSICIAN PLACED SEVERAL PACKING COIL LPS IN THE TARGET LOCATION. AN ADDITIONAL PACKING COIL LP WAS ADVANCED TO THE TARGET LOCATION. THE PHYSICIAN DECIDED TO REPOSITION THE PACKING COIL LP IN THE TARGET LOCATION. WHILE RETRACTING THE PACKING COIL LP, THE EMBOLIZATION COIL UNINTENTIONALLY DETACHED IN THE MICROCATHETER. THE MICROCATHETER CONTAINING THE EMBOLIZATION COIL WAS REMOVED FROM THE PATIENT, AND THE PACKING COIL LP WAS FLUSHED OUT OF THE MICROCATHETER. THE PROCEDURE WAS COMPLETED WITH MORE PACKING COIL LPS AND THE SAME MICROCATHETER. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23776784 ↗MalfunctionNov 3, 2025Premature Separation; Premature Separation
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE USING A PACKING COIL LP. DURING THE PROCEDURE, IT WAS REPORTED THAT THE COIL HAD UNINTENTIONALLY DETACHED. THE PHYSICIAN USED A SNARE DEVICE TO SUCCESSFULLY REMOVE THE PACKING COIL LP. THE PROCEDURE WAS COMPLETED USING A NEW PACKING COIL LP. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23458359 ↗MalfunctionDec 13, 2024Material Deformation; Premature Separation; Material Deformation; Premature Separation
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN THE MIDDLE MENINGEAL ARTERY (MMA) USING PACKING COIL LPS AND A NON-PENUMBRA MICROCATHETER. DURING THE PROCEDURE, THE PHYSICIAN SUCCESSFULLY IMPLANTED ONE PACKING COIL LP INTO THE TARGET LOCATION. THE PHYSICIAN THEN ADVANCED ANOTHER PACKING COIL LP INTO THE TARGET LOCATION. WHILE RETRACTING THE PACKING COIL LP FOR REPOSITIONING, THE PHYSICIAN KINKED THE PUSHER ASSEMBLY OF THE PACKING COIL LP AND THE COIL UNINTENTIONALLY DETACHED. THE PHYSICIAN THEN USED THE PUSHER ASSEMBLY OF THE PACKING COIL LP TO SUCCESSFULLY PUSH THE REMAINING FIVE CENTIMETERS OF THE COIL OUT OF MICROCATHETER, AND INTO THE TARGET LOCATION. THE PROCEDURE WAS SUCCESSFULLY COMPLETED AT THIS POINT AND NO ADDITIONAL COILS WERE NECESSARY. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20926781 ↗MalfunctionNov 23, 2024Migration; Migration
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN THE GASTRODUODENAL ARTERY (GDA) USING A PACKING COIL LP, RUBY COIL LPS, AND A NON-PENUMBRA MICROCATHETER. DURING THE PROCEDURE, THE PHYSICIAN PLACED THREE RUBY COIL LPS IN THE TARGET LOCATION USING THE MICROCATHETER. THE PHYSICIAN THEN SUCCESSFULLY PLACED ANOTHER PACKING COIL LP IN THE VESSEL. WHILE POWER INJECTING CONTRAST, THE LAST PACKING COIL LP PLACED WAS PUSHED FROM THE GDA TO THE RIGHT HEPATIC ARTERY. IT WAS REPORTED THAT THE PHYSICIAN DID NOT HAVE A SMALL ENOUGH SNARE DEVICE TO BE USED TO REMOVE THE PACKING COIL LP DUE TO THE TORTUOSITY AND DIAMETER OF THE VESSEL. THEREFORE, THE PACKING COIL LP WAS LEFT IN THE RIGHT HEPATIC ARTERY. THE PHYSICIAN DECIDED TO END THE PROCEDURE AT THIS POINT. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.
Patient problems: Foreign Body In Patient
MAUDE report 20766097 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page